Cargando…

Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany

Detalles Bibliográficos
Autores principales:	Blüthner, E., Pape, U.-F., Blumenstein, I., Wichmann, J., Tacke, F., Moosburner, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032092/ http://dx.doi.org/10.1016/j.clnesp.2022.09.547

Ejemplares similares

Severe acute respiratory syndrome coronavirus 2 antibody prevalence in adult patients with short bowel syndrome—A German multicenter cross‐sectional study
por: Blüthner, Elisabeth, et al.
Publicado: (2022)

Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure—A Nested Matched Pair Real-World Study
por: Blüthner, Elisabeth, et al.
Publicado: (2023)

Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome
por: Büttner, Janine, et al.
Publicado: (2023)

Prevalence of colorectal cancer and its precursor lesions in symptomatic patients under 55 years of age undergoing total colonoscopy: results of a large retrospective, multicenter, controlled endoscopy study
por: Stratmann, Katharina, et al.
Publicado: (2021)

Chronic intestinal failure and short bowel syndrome in Crohn’s disease
por: Aksan, Aysegül, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 IgG antibodies among dental teams in Germany
por: Mksoud, Maria, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany
por: Tönshoff, Burkhard, et al.
Publicado: (2021)

Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV)
por: Kindgen-Milles, Detlef, et al.
Publicado: (2021)

Assessing Non-Invasive Liver Function in Patients with Intestinal Failure Receiving Total Parenteral Nutrition—Results from the Prospective PNLiver Trial
por: Blüthner, Elisabeth, et al.
Publicado: (2020)

Prevalence of SARS-CoV-2 antibodies in hemodialysis patients in Senegal: a multicenter cross-sectional study
por: Seck, Sidy Mohamed, et al.
Publicado: (2021)

Estimating the share of SARS-CoV-2-immunologically naïve individuals in Germany up to June 2022
por: Maier, Benjamin F., et al.
Publicado: (2023)

Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany
por: Michelitsch, Anna, et al.
Publicado: (2020)

Sero-prevalence of anti-SARS-CoV-2 antibodies among healthcare workers: A multicenter study from Egypt
por: El-Sokkary, Rehab H., et al.
Publicado: (2021)

Prevalence of anti-SARS-CoV-2 antibody in hemodialysis facilities: a cross-sectional multicenter study from Madinah
por: Housawi, Abdulrahman A., et al.
Publicado: (2022)

Antibodies against Rickettsia spp. in Hunters, Germany
por: Jansen, Andreas, et al.
Publicado: (2008)

Antibody responses to SARS-CoV-2 short-lived
por: Vabret, Nicolas
Publicado: (2020)

Antibodies against SARS-CoV-2 Suggestive of Single Events of Spillover to Cattle, Germany
por: Wernike, Kerstin, et al.
Publicado: (2022)

Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease
por: Bosa, Luca, et al.
Publicado: (2022)

Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease
por: Martin-Arranz, M. D., et al.
Publicado: (2023)

The Second Wave of SARS-CoV-2 Circulation—Antibody Detection in the Domestic Cat Population in Germany
por: Michelitsch, Anna, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 antibodies in the Republic of Congo in mid-2021
por: Niama, Fabien R., et al.
Publicado: (2022)

Saliva SARS-CoV-2 Antibody Prevalence in Children
por: Keuning, Maya W., et al.
Publicado: (2021)

Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies
por: Mahler, Michael, et al.
Publicado: (2005)

Impact of the COVID-19 outbreak and the serum prevalence of SARS-CoV-2 antibodies in patients with inflammatory bowel disease treated with biologic drugs
por: Bossa, Fabrizio, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
por: Le Vu, Stéphane, et al.
Publicado: (2021)

Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence
por: Miller, Cheryl N., et al.
Publicado: (2022)

SARS-CoV-2 in inflammatory bowel disease population: Antibodies, disease and correlation with therapy
por: Conti, Clara Benedetta, et al.
Publicado: (2022)

Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022
por: Offergeld, Ruth, et al.
Publicado: (2023)

Validation of risk scores for allograft failure after liver transplantation in Germany: a retrospective cohort analysis
por: Moosburner, Simon, et al.
Publicado: (2023)

Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
por: Arteaga-Müller, Giovanna Yazmin, et al.
Publicado: (2021)

Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers
por: Wang, Ralph C., et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers
por: Morris, Claudia R., et al.
Publicado: (2021)

Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon
por: Bahlawan, Omar, et al.
Publicado: (2022)

SARS-CoV-2 and West Nile Virus Prevalence Studies in Raccoons and Raccoon Dogs from Germany
por: Keller, Markus, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
por: Hein, Alexander, et al.
Publicado: (2022)

SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients
por: Korth, Johannes, et al.
Publicado: (2020)

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
por: Aziz, N. Ahmad, et al.
Publicado: (2021)

Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
por: Sorg, Anna-Lisa, et al.
Publicado: (2022)

Impact of SARS-CoV-2 on the mobility behaviour in Germany
por: Anke, Juliane, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 Antibodies after the Omicron Surge, Kingston, Jamaica, 2022
por: Anzinger, Joshua J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8egrsuafu0sjs0uas5an4s6vv0